In an 8-K filing after the close Wednesday, Nastech Pharmaceutical (Nasdaq: NSTK) disclosed it has commenced a plan to terminate ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE